Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
4.360
-0.120 (-2.68%)
Nov 14, 2025, 4:00 PM EST - Market closed
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $271.47 million as of November 14, 2025. Its market cap has increased by 21.18% in one year.
Market Cap
271.47M
Enterprise Value
214.29M
1-Year Change
21.18%
Ranking
Category
Stock Price
$4.36
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $271.47M, a decrease of -48.17%. That is a compound annual growth rate of -14.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 271.47M | 192.64% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 919.17B |
| Johnson & Johnson | 470.80B |
| AbbVie | 414.08B |
| UnitedHealth Group | 302.19B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 231.27B |
| Abbott Laboratories | 224.45B |